Atgen Co. Ltd.

Atgen Co. Ltd.
Stock Exchange Korea Exchange
EPS
KRW787.5
Market Cap
KRW381.7 B
Shares Outstanding
24.71 M
Public Float
20.47 M

Profile

Address
1st & 6th Floor, Health Care Park
Seongnam-si GY 13605
Korea, Republic Of
Employees -
Website http://www.nkvue.com
Updated 09/14/2018
ATGen Co., Ltd. engages in the development, manufacture, and sale of recombinant proteins and monoclonal antibodies. Its products include NK cells under NK Vue brand, recombinant proteins, and monoclonal antibodies. The company was founded on January 14, 2002 and is headquartered at Seongnam-si, South Korea.

Financials

View All

Sang-Woo Park
Chief Executive Officer & Director
Yong-Hwan Cho
Senior Managing Director & Head-Operations